Revealed: Eplerenone's "unexplained" benefits in post-MI heart failure TheHeart.Org Washington, DC - As a weapon against postinfarction heart failure, eplerenone (Inspra, Pfizer) seems to be a triple threat. At least three separate therapeutic properties of the aldosterone antagonist contributed to the drug's significant clinical ... |
